HIKAL
Sector : Pharmaceuticals and health care | Kalyani Group | Smallcap | BSE
Here's the live share price of Hikal along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.15₹ -0.35
As on Oct 31, 2025, 4:01 PM IST
Hikal Price Performance
Today's LowToday's High
₹237.35₹240.95
₹240.00
52 Weeks' Low52 Weeks' High
₹236.50₹464.50
₹240.00
Open Price
₹240.50
Prev. Close
₹240.35
Volume
6,803
Over the last 5 years, the share price of Hikal has gained 7.99% CAGR. Over the past year, the corresponding return has been -36.90%.
Hikal’s current P/E of 46.75x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Hikal Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Hikal | -1.15 | -5.88 | -25.75 | -39.77 | -36.90 | -10.09 | 7.99 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Hikal has declined 36.90% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Hikal has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Hikal Financials
Hikal Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 242.52 | 241.25 |
| 10 | 241.47 | 242.18 |
| 20 | 245.73 | 245.35 |
| 50 | 254.39 | 260.39 |
| 100 | 298 | 287.65 |
| 200 | 339.42 | 316.25 |
Hikal Share Holding Pattern
In the latest quarter, Hikal remained same as its previous close in promoter holding, while DII stake increased to 5.15%, FII holding fell to 4.23%, and public shareholding moved down to 21.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Hikal Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 10,96,943 | 0.44 | 27.6 | |
| 3,93,821 | 0.76 | 9.91 |
* Excluding Index & Arbitrage Funds
Hikal Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 31, 2025, 11:11 PM IST | Hikal Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 31, 2025, 10:54 PM IST | Hikal Ltd. - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Resul |
| Oct 09, 2025, 5:10 PM IST | Hikal Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 07, 2025, 10:45 PM IST | Hikal Ltd. - Disclosure Under Regulation 30 Of SEBI Listing Regulations |
| Oct 07, 2025, 10:35 PM IST | Hikal Ltd. - Newspaper Advertisement Regarding Saksham Niveshak For Updating KYC And Re-Lodgment Of Transfer Requests Of Phys |
About Hikal
Hikal Ltd. is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1859.80 Cr. and Equity Capital is Rs. 24.70 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address717/718, Maker Chambers V, Mumbai Maharashtra 400021
- Contact
Management
- Mr. Jai HiremathExecutive Chairman
- Mr. Sameer HiremathVice Chairman & Mng.Director
- Mr. Sarangan SureshWhole Time Director
- Ms. Sugandha HiremathNon Executive Director
- Mr. Amit KalyaniNon Executive Director
- Mrs. Shivani Bhasin SachdevaInd. Non-Executive Director
- Mr. Shrikrishna AdivarekarInd. Non-Executive Director
- Mr. Ramachandra KaundinyaInd. Non-Executive Director
- Mr. Berjis DesaiInd. Non-Executive Director
- Mr. Ravi KapoorInd. Non-Executive Director
- Mr. Ranjana S SalgaocarInd. Non-Executive Director
FAQs on Hikal Share Price
What is the share price of Hikal?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Hikal is ₹240.00 as on Oct 31, 2025.
What kind of stock is Hikal?
The Hikal is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Hikal?
The market cap of Hikal is ₹2,959.22 Cr as on Oct 31, 2025.
What are today's High and Low prices of Hikal?
Today’s highest and lowest price of Hikal are ₹240.95 and ₹237.35.
What are the 52 Week High and 52 Week Low of Hikal?
The 52-week high/low is the highest and lowest price at which Hikal stock has traded in the past 52-week or nearly a year. The 52-week high of Hikal is ₹464.50 and 52-week low of Hikal is ₹236.50 as on Oct 31, 2025.
How has the Hikal performed historically in terms of returns?
The Hikal has shown returns of -0.15% over the past day, -5.88% for the past month, -25.75% over 3 months, -36.9% over 1 year, -10.09% across 3 years, and 7.99% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Hikal?
P/E ratio of and PB ratio of Hikal are 46.75 and 2.34 on Oct 31, 2025. While the company gives a dividend yield of 0.58 per annum.
✕
Market Pulse